Phantomics
About Phantomics
Phantomics is a healthcare AI company dedicated to overcoming cardiovascular diseases through accurate and reliable AI-driven diagnostic imaging technologies. Founded in 2019, the company integrates advanced artificial intelligence with medical imaging to develop next-generation solutions capable of detecting disease biomarkers and predicting prognoses. Their mission is to revolutionize early detection and prevention of cardiovascular and other critical diseases, aiming to make state-of-the-art medical technologies accessible to every hospital worldwide.
The company’s flagship solution, Myomics, utilizes AI-powered, non-invasive cardiac MRI and CT analysis to provide rapid and accurate diagnostic results for myocardial diseases such as heart failure, myocarditis, and amyloidosis. Myomics is actively used in over 20 major general and secondary hospitals in South Korea, as well as in 19 international medical institutions, and has received regulatory approvals including U.S. FDA clearance. Phantomics is also expanding its research and development to include non-invasive diagnostic solutions for liver and muscle wasting diseases.
Phantomics aims to lower the barriers of cardiac MRI and CT examinations by providing standardized AI solutions, thereby creating a beneficial ecosystem for both medical professionals and patients. The company’s technology provides quantitative and precise disease diagnosis and prognosis prediction by comprehensively analyzing medical images and biomarkers, enabling physicians to make accurate decisions.
Focus Areas
Business Intelligence
| Key Investors | Devsisters Ventures, Bigbang Angels, COMEUP STARS, DAYLI Partners, Tech Incubator Program for Startup |
| Partnerships | GE HealthCare Korea, Philmedis Clinic, Yonsei University Severance Hospital, Siemens Healthineers Korea, Yujeong Meditech |
| Technology | AI-powered diagnostic platforms, advanced AI algorithms, image biomarker technology, cloud-native solutions, automated contour detection, quantitative analysis (ejection fraction, stroke volume, mass, wall motion, strain, T1/T2 mapping, tissue characterization, LGE quantification, flow assessment) |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
Phantomics' solutions, like Myomics and Angiomics, offer physicians a 'virtual fellow' for faster, more accurate, and standardized cardiac imaging analysis. This can significantly reduce the burden of manual interpretation, improve diagnostic confidence, and enable earlier intervention for critical cardiovascular conditions. The non-invasive nature of their image biomarker technology provides a safer alternative to traditional invasive procedures like myocardial tissue biopsies. Physicians can leverage these tools to streamline workflows, enhance diagnostic capabilities even without immediate access to highly specialized experts, and ultimately improve patient outcomes through precise and timely diagnoses.
Phantomics' solutions are designed for seamless integration into existing healthcare IT infrastructure, including hospital information systems, and are accessible via web and mobile platforms. They are actively pursuing partnerships with medical imaging platform vendors and have a strategic MOU with GE HealthCare Korea to co-develop new product features and improve image quality and scan protocols, indicating strong potential for integration with various imaging equipment and PACS systems.
What the Web Says
Phantomics appears to be a company with a focus on medical imaging and AI, specifically in the cardiovascular space. While direct product reviews on major platforms like G2, Capterra, or even dedicated healthcare IT review sites are scarce, the company's LinkedIn presence and academic collaborations suggest a strong scientific foundation. Employer reviews are also not readily available on Glassdoor or Reddit, indicating it might be a smaller or less publicly reviewed entity.
Overall: MixedStrengths
- Focus on cutting-edge AI in cardiovascular imaging.
- Potential for significant impact in medical diagnostics.
- Likely strong scientific and technical expertise within the company.
- Collaborations with academic institutions (implied by research focus).
- Addresses a critical need in healthcare for improved diagnostics.
- Innovative approach to medical data analysis.
Limitations
- Lack of readily available product reviews on major platforms (G2, Capterra).
- Limited public information regarding customer satisfaction.
- Absence of employer reviews on Glassdoor or Reddit.
- Might be a relatively new or niche company, leading to less public discourse.
- Potential for long sales cycles typical in healthcare IT.
- High regulatory hurdles inherent in medical device/software development.
Based on reviews from: G2 (no direct reviews found), Glassdoor (no direct reviews found), Capterra (no direct reviews found), Healthcare IT reviewers (no specific reviews found, general industry knowledge applied), Reddit (no direct reviews found), LinkedIn (company profile, general industry presence)
Last updated: 2026-07-18
Videos
News, demos, and interviews about Phantomics.
Videos load interactively. If none appear, search YouTube for Phantomics →
Press & Coverage
Frequently Asked Questions
Related Companies
Surgical Reality is a healthcare AI company that specializes in advanced AI-powered 3D medical imaging and surgical planning software for thoracic surgery. Their core product, the Surgical Reality Viewer, converts standard CT scans into high-fidelity, patient-specific 3D models of the entire lung within minutes. This technology is designed to assist trained healthcare professionals with preoperative […]
Oxipit, now a part of the Sectra Group, is a leading healthcare AI company specializing in AI-driven medical imaging solutions for radiology. Founded by experts in medicine and data science, the company aims to address the global shortage of radiologists and improve diagnostic efficiency and accuracy. Their flagship product line, the CXR Suite, includes CE-certified […]
Cercare Medical is an AI-powered healthcare company specializing in advanced perfusion imaging solutions for neurological diseases. Their software, the Cercare Medical Neurosuite, processes CT, CBCT, and MRI data to provide detailed insights into brain health. This technology goes beyond traditional perfusion imaging by integrating proprietary biomarkers that measure not only blood flow but also oxygenation, […]
CARPL.ai is a vendor-neutral Artificial Intelligence (AI) platform designed to empower radiologists by providing a unified interface for accessing, assessing, integrating, and monitoring AI solutions within their clinical workflows. The platform addresses the challenges healthcare providers face in navigating the fragmented landscape of numerous AI applications by offering a single point of access, data channel, […]
Caption Health, formerly known as Bay Labs and now part of GE HealthCare, is a pioneering medical artificial intelligence (AI) company dedicated to expanding access to high-quality ultrasound examinations. The company’s core offering is the Caption AI platform, which utilizes AI to guide healthcare providers, including those without extensive specialized training, in acquiring and interpreting […]
Smart Soft Healthcare is a healthcare startup dedicated to transforming spine diagnostics and treatment through Artificial Intelligence (AI). Established in 2021 as a spin-off from SmartSoft, the company aims to deliver more effective and economical healthcare solutions. Their primary product, CoLumbo, is an AI-powered software designed to assist in the interpretation of lumbar spine MRI […]